Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.88−0.03 (-3.52%)
Close on Nov 13, 2026Market cap $7.06MP/E –Yield –
Immuron enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Immuron's enterprise value was $688.33K on Nov 11, 2026, against $8.02M a year earlier. Over the last 5 years it ranged from -$11.72M to $21.25M, with a median of $2.47M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $688.33K | -72.6% |
| 2025 | Dec 31, 2025 | $2.51M | +1.6% |
| 2024 | Dec 31, 2024 | $2.47M | – |
| 2023 | Dec 29, 2023 | -$11.72M | – |
| 2022 | Dec 30, 2022 | -$3.21M | -138.5% |
| 2019 | Jul 31, 2019 | $8.35M | -46.2% |
| 2018 | Dec 31, 2018 | $15.53M | +104.8% |
| 2017 | Dec 29, 2017 | $7.58M | +33.7% |
| 2016 | Dec 30, 2016 | $5.67M | – |
See a number that looks wrong?